RESTON, Va.-The power of molecular imaging-and its ability to see through layers of skin and tissue to detect-and treat-heart disease, brain disorders and cancer-will be explored during SNM's Mid-Winter Educational Symposium Feb. 15-18, 2007, at the Hyatt Regency in San Antonio, Texas.

"The merging of advances in molecular biology with new technologies, hybrid imaging and existing nuclear medicine techniques helps us understand the molecular basis of disease and provides a way to improve patient care in the future," said SNM President Martin P. Sandler, who speaks for more than 16,000 physician, technologist and scientist members.

SNM, the largest professional society for molecular imaging and nuclear medicine, joins forces with the American College of Nuclear Physicians to provide an exceptional educational program examining advances in cardiovascular and brain molecular imaging, treatment of bone tumors, use of radiotracer imaging with heart disease, treatment of cancer in children, instrumentation, and targeted imaging and therapy. Noted physicians, scientists and technologists will present the latest news about using molecular imaging and nuclear medicine for the diagnosis, management and treatment of diseases to several hundred physicians, radiologists, cardiologists, oncologists, technologists, pharmacists, medical physicists and other health care professionals.


The SNM and ACNP programs include a consumer's perspective on exploring ethical violations of physicians, malpractice issues related to imaging specialties, building and growing a medical imaging practice, cardiac MRI techniques, applications of MRI with ischemic heart disease, principles of cardiac CT, advances in cardiovascular and brain molecular imaging, MIBG therapy in children and adults, clinical brain imaging and nuclear medicine technology, therapy of bone tumors and the use of radiotracer imaging in a wide spectrum of heart diseases.

Topics for technologists include updates on wide-beam reconstruction, a basic arrhythmia review, an introduction to CT, pitfalls and artifacts in PET and PET/CT, radiation safety and a molecular imaging overview.

Sessions were developed with participation from members of SNM's Brain Imaging, Cardiovascular, Computer and Instrumentation, Nuclear Oncology and Pediatric councils as well as the Molecular Imaging and PET centers of excellence, SNM's Technologist Section and ACNP. ACNP is holding its 33rd annual meeting in conjunction with SNM's symposium.

For additional information about the program, housing and how to register, please visit SNM's Web site at http://www.snm.org/mwm.

More Industry Headlines